Pertti Jääskeläinen

5.5k total citations
27 papers, 664 citations indexed

About

Pertti Jääskeläinen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Pertti Jääskeläinen has authored 27 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Pertti Jääskeläinen's work include Cardiomyopathy and Myosin Studies (25 papers), Cardiovascular Function and Risk Factors (14 papers) and Cardiovascular Effects of Exercise (14 papers). Pertti Jääskeläinen is often cited by papers focused on Cardiomyopathy and Myosin Studies (25 papers), Cardiovascular Function and Risk Factors (14 papers) and Cardiovascular Effects of Exercise (14 papers). Pertti Jääskeläinen collaborates with scholars based in Finland, United States and Denmark. Pertti Jääskeläinen's co-authors include Johanna Kuusisto, Markku Laakso, Petri Sipola, Keijo Peuhkurinen, Raija Miettinen, Päivi Kärkkäinen, Anita Naukkarinen, Jussi Pihlajamäki, Satu Kärkkäinen and Kirsi Lauerma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Pertti Jääskeläinen

26 papers receiving 650 citations

Peers

Pertti Jääskeläinen
Ole Havndrup Denmark
C Limas United States
Julia Münch Germany
H. A. Rockman United States
Sean J. Jurgens United States
Ole Havndrup Denmark
Pertti Jääskeläinen
Citations per year, relative to Pertti Jääskeläinen Pertti Jääskeläinen (= 1×) peers Ole Havndrup

Countries citing papers authored by Pertti Jääskeläinen

Since Specialization
Citations

This map shows the geographic impact of Pertti Jääskeläinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pertti Jääskeläinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pertti Jääskeläinen more than expected).

Fields of papers citing papers by Pertti Jääskeläinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pertti Jääskeläinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pertti Jääskeläinen. The network helps show where Pertti Jääskeläinen may publish in the future.

Co-authorship network of co-authors of Pertti Jääskeläinen

This figure shows the co-authorship network connecting the top 25 collaborators of Pertti Jääskeläinen. A scholar is included among the top collaborators of Pertti Jääskeläinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pertti Jääskeläinen. Pertti Jääskeläinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sipola, Petri, Tiina Heliö, Pertti Jääskeläinen, et al.. (2025). Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study. Scientific Reports. 15(1). 28499–28499.
2.
Pentikäinen, Markku O., Piia Simonen, Helena Tuunanen, et al.. (2024). Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH). SHILAP Revista de lepidopterología. 7. 100191–100191. 1 indexed citations
3.
Pentikäinen, Markku O., et al.. (2024). Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland. IJC Heart & Vasculature. 55. 101534–101534. 1 indexed citations
4.
Jääskeläinen, Pertti, Jagadish Vangipurapu, Teemu Kuulasmaa, et al.. (2019). Genetic Basis and Outcome in a Nationwide Study of Finnish Patients with Hypertrophic Cardiomyopathy. ESC Heart Failure. 6(2). 436–445. 23 indexed citations
5.
Sipola, Petri, Tiina Heliö, Pertti Jääskeläinen, et al.. (2019). CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation. Scientific Reports. 9(1). 5960–5960. 3 indexed citations
6.
Heliö, Tiina, Jorma Kokkonen, Heini Huhtala, et al.. (2018). Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations. Journal of Electrocardiology. 51(6). 983–989. 2 indexed citations
7.
Kuusisto, Johanna, Vesa Kärjä, Petri Sipola, et al.. (2012). Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart. 98(13). 1007–1013. 119 indexed citations
8.
Jääskeläinen, Pertti, Tiina Heliö, Katriina Aalto‐Setälä, et al.. (2012). Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population. Annals of Medicine. 45(1). 85–90. 30 indexed citations
10.
12.
Sipola, Petri, Kirsi Lauerma, Pertti Jääskeläinen, et al.. (2005). Cine MR Imaging of Myocardial Contractile Impairment in Patients with Hypertrophic Cardiomyopathy Attributable to Asp175Asn Mutation in the α-Tropomyosin Gene. Radiology. 236(3). 815–824. 25 indexed citations
13.
Kärkkäinen, Satu, Tiina Heliö, Pertti Jääskeläinen, et al.. (2004). Two novel mutations in the β-Myosin Heavy Chain Gene Associated with Dilated Cardiomyopathy. European Journal of Heart Failure. 6(7). 861–868. 28 indexed citations
14.
Jääskeläinen, Pertti, Raija Miettinen, Päivi Kärkkäinen, et al.. (2004). Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes. Annals of Medicine. 36(1). 23–32. 37 indexed citations
15.
Sipola, Petri, Kirsi Lauerma, Minna Husso-Saastamoinen, et al.. (2003). First-Pass MR Imaging in the Assessment of Perfusion Impairment in Patients with Hypertrophic Cardiomyopathy and the Asp175Asn Mutation of the α-Tropomyosin Gene. Radiology. 226(1). 129–137. 51 indexed citations
16.
Kärkkäinen, Satu, Keijo Peuhkurinen, Pertti Jääskeläinen, et al.. (2002). No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy. American Heart Journal. 143(6). 11–14. 15 indexed citations
17.
Jääskeläinen, Pertti, Johanna Kuusisto, Raija Miettinen, et al.. (2002). Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. Journal of Molecular Medicine. 80(7). 412–422. 72 indexed citations
18.
Jääskeläinen, Pertti, et al.. (1999). The Cardiac Troponin I Gene Is Not Associated with Hypertrophic Cardiomyopathy in Patients From Eastern Finland. Journal of Molecular and Cellular Cardiology. 31(11). 2031–2036. 13 indexed citations
19.
Tikanoja, Tero, Pertti Jääskeläinen, Markku Laakso, & Johanna Kuusisto. (1999). Simultaneous hypertrophic cardiomyopathy and ventricular septal defect in children. The American Journal of Cardiology. 84(4). 485–486. 4 indexed citations
20.
Jääskeläinen, Pertti, et al.. (1998). The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. Journal of the American College of Cardiology. 32(6). 1709–1716. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026